Vita Coco Raises EBITDA Outlook 9.5% as Q4 Margin Heads to 33%
Vita Coco raised its 2026 adjusted EBITDA guidance after a quarter in which sales rose 34%, but the headline combines two different stories: robust underlying demand and a large first contribution from the Copra acquisition.
The beverage company reported third-quarter net sales of $243.8 million, up from $182.3 million a year earlier. Copra supplied 16.0 percentage points of the 33.7% reported increase, leaving organic growth of 17.8%. That means the acquired business accounted for almost half of the reported growth rate, while the existing operation still expanded at a pace few packaged-drink companies are matching.
The figures come from Vita Coco's third-quarter results released on 22 October 2026. The filing also points to a near-term margin squeeze: management expects fourth-quarter gross margin of about 33%, down from 38% in the third quarter, because costs are rising before planned pricing takes effect in early 2027.
The guidance upgrade is larger in profit than in sales
Vita Coco lifted its full-year sales range to $810 million to $820 million from $790 million to $805 million. At the midpoint, that is a $17.5 million increase, or about 2.2%.
Adjusted EBITDA guidance rose to $170 million to $175 million from $154 million to $161 million. The midpoint increased by $15 million, or about 9.5%. The much larger percentage change in the profit outlook indicates stronger-than-expected operating performance, including volume, lower tariffs and selling-cost leverage, rather than a simple pass-through of the acquired revenue.
Measure | Previous guidance | New guidance | Midpoint change |
2026 net sales | $790m-$805m | $810m-$820m | +$17.5m, about 2.2% |
Adjusted EBITDA | $154m-$161m | $170m-$175m | +$15m, about 9.5% |
Full-year gross margin | About 40% | About 40% | No change |
Q4 gross margin | Not specified in prior range | About 33% | Cost pressure ahead of pricing |
Adjusted EBITDA is a non-GAAP measure and excludes items management does not treat as part of ongoing performance. The company did not provide full-year GAAP net-income guidance, citing the difficulty of forecasting currency movements and other items.
Copra transformed private label growth
Private-label sales rose 152% in the quarter. Volume increased 76.7%, including a 109.9% jump in the Americas and 23.1% internationally. Copra, acquired in July for net cash consideration of $139 million, primarily affected the private-label line, while its branded and commodity sales were recorded in Other.
The distinction matters because private label usually carries different economics from a branded flagship product. It can deepen retailer relationships and improve factory utilization, but it may also dilute gross margin. Vita Coco explicitly identified Copra and the strong private-label mix as headwinds to its gross-margin outlook.
The acquisition did not create all of the growth. Vita Coco Coconut Water sales increased 15%, supported by a 15.8% rise in case-equivalent volume. International branded volume grew 50.5%, compared with 8.5% in the Americas. The smaller international base magnifies the percentage, but the result shows that expansion outside the core US market is becoming financially meaningful.
International segment sales reached $45.3 million, up 48% from $30.6 million. Americas sales rose 31% to $198.6 million. International still represented less than one-fifth of group revenue, but it supplied a disproportionate share of branded volume growth.
A strong quarter does not remove the cost problem
Third-quarter gross profit rose to $92.7 million from $68.7 million. Gross margin was 38.0%, almost unchanged from 37.7% a year earlier. Higher volume, Copra and minimal tariff expense helped gross profit, while domestic logistics costs and the acquired business's lower-margin mix worked in the opposite direction.
The more revealing signal is management's fourth-quarter expectation. Gross margin is forecast near 33% because product, ocean freight and other transportation costs are increasing, while offsetting price increases are not expected until early 2027.
A five-percentage-point move from the third-quarter margin would be material. It does not automatically imply that annual profitability is deteriorating, because quarter-to-quarter mix and timing can be volatile. It does show that the next phase of growth will be tested by how quickly the company can price, how consumers respond and whether freight costs stabilize.
The annual margin target remains about 40%, helped by lower tariffs, tariff refunds and earlier pricing. Year-to-date gross margin was 42.2%, up from 36.9%, and tariff refunds contributed 240 basis points. Those benefits make the full-year number stronger than the underlying exit rate entering 2027.
Cash remains strong after a large acquisition outflow
Vita Coco ended September with $152 million in cash and no debt. Cash fell $127 million from the end of the second quarter, primarily because the company used $139 million for the Copra acquisition.
Accounts receivable increased to $129 million from $82 million at the end of 2025. Management attributed that to strong quarterly sales and Copra's inclusion. Inventory was $111 million, unchanged from year-end despite adding Copra inventory, because strong shipments drew down the legacy inventory base.
The company also continued buying back shares. It had repurchased about $94 million as of 22 October and had $11 million remaining under the $105 million authorization. With no debt, the balance sheet can absorb the acquisition, but investors will still need to see whether Copra produces cash returns that justify the purchase price.
What the numbers mean for coconut suppliers and retailers
For coconut processors, the 77% private-label volume increase and Copra integration point to more demand for Thai Nam Hom coconut water and associated raw-material, packaging and freight capacity. The filing does not disclose farm-gate coconut prices, supplier contracts or procurement volumes, so the effect on growers cannot be quantified from the results alone.
Retailers gain a larger supplier capable of serving branded and private-label segments. That can simplify category sourcing, but it also gives Vita Coco a wider commercial footprint. The competitive question is whether the company can use that scale to sustain distribution and household penetration without triggering price resistance when increases arrive in 2027.
Consumers should not assume the guidance upgrade means prices will remain unchanged. Management has already signaled that price actions are expected early next year. The important unknown is elasticity: how much volume growth persists when the cost response reaches the shelf.
The four indicators that matter next
First, fourth-quarter gross margin will show whether the 33% forecast proves conservative or whether freight and product costs are accelerating further. Second, branded volume after price increases will test consumer demand more directly.
Third, Copra's contribution should be separated into acquired revenue, organic growth and margin so investors can judge integration rather than merely consolidated scale. Fourth, international growth needs to remain strong enough to diversify a business still dominated by the Americas.
Vita Coco's quarter was genuinely strong, but the quality of the next result will depend less on another headline sales increase than on the bridge from 33% fourth-quarter margin back toward a sustainable level after pricing, freight and acquisition mix are fully reflected.
Sources and methodology
Agrilinkage based this analysis on Vita Coco's 22 October 2026 earnings release and financial tables. Midpoint changes, segment growth and acquisition-share calculations are derived from the reported figures. Adjusted EBITDA and organic growth are company-defined non-GAAP measures. Agrilinkage conducted no interviews and did not independently test the products.
Comments